Does THALIDOMIDE Cause Second primary malignancy? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Second primary malignancy have been filed in association with THALIDOMIDE (Thalomid). This represents 0.2% of all adverse event reports for THALIDOMIDE.
34
Reports of Second primary malignancy with THALIDOMIDE
0.2%
of all THALIDOMIDE reports
13
Deaths
9
Hospitalizations
How Dangerous Is Second primary malignancy From THALIDOMIDE?
Of the 34 reports, 13 (38.2%) resulted in death, 9 (26.5%) required hospitalization, and 5 (14.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THALIDOMIDE. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does THALIDOMIDE Cause?
Plasma cell myeloma (1,652)
Off label use (1,356)
Death (1,161)
Neuropathy peripheral (1,068)
Drug ineffective (789)
Pneumonia (694)
Fatigue (643)
Constipation (461)
Thrombocytopenia (429)
Neutropenia (420)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which THALIDOMIDE Alternatives Have Lower Second primary malignancy Risk?
THALIDOMIDE vs THALOMID
THALIDOMIDE vs THEOPHYLLINE
THALIDOMIDE vs THEOPHYLLINE ANHYDROUS
THALIDOMIDE vs THIAMINE
THALIDOMIDE vs THIOCOLCHICOSIDE